CRP and Alzheimer disease: For example, using the Framingham Heart Study (FHS), we found that within carriers of the AD risk genotype, apolipoprotein E4 (APOE 4), elevated blood C-reactive protein (CRP) levels are associated with increased AD risk.(2) This phenomenon is not observed among APOE 2 and APOE 3 carriers.